Quick Answer
Health Catalyst, Inc. reported R&D Expense of $49.77 million for fiscal year 2025.
Health Catalyst, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $49.77M | -14.1% |
| 2024 | $57.95M | -20.2% |
| 2023 | $72.63M | -4.0% |
| 2022 | $75.68M | +20.6% |
| 2021 | $62.73M | +17.2% |
| 2020 | $53.52M | +15.7% |
| 2019 | $46.25M | +19.8% |
| 2018 | $38.59M | +35.6% |
| 2017 | $28.47M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.28M | -13.5% | -0.9% |
| June 30, 2025 | $12.39M | -10.7% | -18.4% |
| March 31, 2025 | $15.19M | +2.1% | +7.0% |
| September 30, 2024 | $14.19M | -19.7% | +2.2% |
| June 30, 2024 | $13.88M | -21.1% | -6.6% |
| March 31, 2024 | $14.87M | -12.9% | -15.8% |
| September 30, 2023 | $17.67M | -14.9% | +0.4% |
| June 30, 2023 | $17.59M | -3.1% | +3.0% |
- Health Catalyst, Inc. showed a decrease of -14.1% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, Health Catalyst, Inc.’s r&d expense has grown by 74.8% (from $28.47 million to $49.77 million).
- The most recent figure is from Health Catalyst, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: